Abstract
The gram-negative bacterium Actinobacillus pleuropneumoniae (APP) is an inhabitant of the porcine upper respiratory tract and the causative agent of porcine pleuropneumonia (PP). In recent years, knowledge about the proinflammatory cytokine and chemokine gene expression that occurs in lung and lymph node of the APP-infected swine has been advanced. However, systematic gene expression profiles on hilar nodes from pigs after infection with Actinobacillus pleuropneumoniae have not yet been reported. The transcriptional responses were studied in hilar nodes (HN) from swine experimentally infected with APP and the control groupusing Agilent Porcine Genechip, including 43,603 probe sets. 9,517 transcripts were identified as differentially expressed (DE) at the p ≤ 0.01 level by comparing the log2 (normalized signal) of the two groups named treatment group (TG) and controls (CG). Eight hundred and fifteen of these DE transcripts were annotated as pig genes in the GenBank database (DB). Two hundred and seventy-two biological process categories (BP), 75 cellular components and 171 molecular functions were substantially altered in the TG compared to CG. Many BP were involved in host immune responses (i.e., signaling, signal transmission, signal transduction, response to stimulus, oxidation reduction, response to stress, immune system process, signaling pathway, immune response, cell surface receptor linked signaling pathway). Seven DE gene pathways (VEGF signaling pathway, Long-term potentiation, Ribosome, Asthma, Allograft rejection, Type I diabetes mellitus and Cardiac muscle contraction) and statistically significant associations with host responses were affected. Many cytokines (including NRAS, PI3K, MAPK14, CaM, HSP27, protein phosphatase 3, catalytic subunit and alpha isoform), mediating the proliferation and migration of endothelial cells and promoting survival and vascular permeability, were activated in TG, whilst many immunomodulatory cytokines were suppressed. The significant changes in the expression patterns of the genes, GO terms, and pathways, led to a decrease of antigenic peptides with antigen presenting cells presented to T lymphocytes via the major histocompatibility complex, and alleviated immune response induced APP of HN. The immune response ability of HN in the APP-infected pigs was weakened; however, cell proliferation and migration ability was enhanced.
Keywords: porcine pleuropneumonia, infection, Actinobacillus pleuropneumoniae, Agilent Porcine Genechip, microarray analyses, cytokine, host defense response
1. Introduction
Members of the Actinobacillus genus (family Pasteurellaceae) are Gram-negative facultative anaerobic bacteria. They range from commensal species of the mammalian respiratory and genital tracts to important pathogens [1,2]. Actinobacillus pleuropneumoniae (APP) is the causative agent of porcine pleuropneumonia (PP), a disease occurring worldwide and causing significant economic losses in the swine industry [3–7]. The disease, which occurs in swine of all ages, is highly infectious, often fatal, and characterized by necrotizing, hemorrhagic bronchopneumonia and serofibrinous pleuritis [8]. APP can spread quickly by air-borne particles and/or touching contaminated surface, and often kill infected animals in the acute phase when extensive lung hemorrhage and necrosis occur. Swine that survived often developed pleurisy, the sequelaes of local necrosis of the pleura, or became healthy carriers of APP. APP can be divided into two biovars based on its nicotinamide adenine dinucleotide (NAD) requirements: biovar 1, which is NAD dependent, and biovar 2, which can synthesize NAD in the presence of specific pyridine nucleotides or their precursors [4].
The porcine lung infected with APP has previously been reported to result in local production of proinflammatory proteins or to mRNA encoding the cytokines interleukin (IL)-1α, IL-1β, IL-6 and the chemokine IL-8 [9,10]. Likewise, bioactive protein and/or mRNA coding for IL-10, IL12p35, TNF-α and IFN-α had been shown to be up-regulated after infection with APP in vivo or in vitro [9–15]. Using cDNA microarrays, Moser and co-workers identified 307 anonymous transcripts in blood leukocytes obtained from pigs that were severely affected by experimental infection with APP [16]. Hedegaard et al. investigated the molecular characterization of the early response in pigs to infection with APP serotype 5B, using cDNA microarrays [17]. In this study, Hedegaard et al. found three subsets of genes that were consistently expressed at different levels depending upon the infection status and a total of 130 genes had different expression profiles in hilar node (HN) tissue samples from infected versus non-infected animals [17]. Mortensen et al. studied the local transcriptional response in different locations of lung from pigs experimentally infected with the respiratory pathogen APP 5B, using porcine cDNA microarrays (DJF Pig 55 K v1) representing approximately 20,000 porcine genes printed in duplicate [18]. Within the lung, Mortensen et al. found a clear division of induced genes as, in unaffected areas a large part of differently expressed genes were involved in systemic reaction to infection, while differently expressed genes in necrotic areas were mainly concerned with homeostasis regulation [18]. Zuo et al. studied the relationship between infection and injury by investigating the whole porcine genome expression profiles of swine lung tissues post-inoculated with experimental APP, and found 11,929 transcripts differentially expressed at the p ≤ 0.01 level [19]. Many proinflammatory-inflammatory cytokines were activated and involved in the regulation of the host defense response at the site of inflammation; while the cytokines involved in regulation of the host immune response were suppressed [19].
APP often kill infected swine in the acute phase, the lung and pleural of dead animals character by necrotizing, hemorrhagic bronchopneumonia and serofibrinous pleuritis. HN is one of the important immune organs adjacent to lung. Thus, transcriptional profiling of whole porcine genome in HN sampled from inoculated versus non-inoculated swine would lead to greater knowledge of the host response dynamics to bacterial infection in the lung. This knowledge is important to obtain a more complete picture of the lung-specific host reaction in the pathogenesis of respiratory infection.
In the present study, the Agilent Whole Porcine Genome Oligo Microarrays were used to detect the changes in gene expression of infected pigs’ HN from non-inoculated animals. Ten transcripts (the top six up-regulated and the top four down-regulated in microarray data) were selected to verify the accuracy and reproducibility of the microarray data by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR).
2. Results
2.1. Clinical Symptoms and Necropsy Findings
Swines showed hyperthermia (40.6–42.0 °C), dyspnea and anorexia after being inoculated with APP 24–48 h. Two swines died with respiratory distress at post-inoculation 36–48 h. In the autopsy, the lungs were severely damaged by acute, multifocal, fibrino-necrotizing and hemorrhagic pneumonia complicated by acute diffuse fibrinous pleuritis. The HN were enlarged and congested. No lesions in CG were observed. The infected swines had lung and pleural lesions of variable severity consistent with acute pleuropneumonia, whereas the surrounding lung and pleural tissue appeared normal.
Histopathological lesions were not observed in CG. However, lesions in TG’s in TG’s HN were characterized by loose medulla, congestion, edema, fibrinous exudation and neutrophils infiltration (Figure 1).
2.2. Microarray Profiling
Expression profiling was conducted using a commercially available Agilent Porcine Genechip that included 43,603 probe sets. The transcriptome of the HN was determined. Expression was detected for 29,105 probes (66.75% of all probe sets) of the CG. A total of 29,646 probes (67.99% of all probe sets) were expressed in TG. When probe sets’ intensities had been normalized and filtered, there were still 26,353 probes used to identify significantly DE genes. There were 9,517genes identified as DE at the p ≤ 0.01 level by comparing the log2 (normalized signal) of the two groups (CG vs. TG) using t-test analysis.
Hierarchical clustering was applied to the mean log-ratio of the replicated spots from the DE genes by the average linkage and used euclidean distance as the similarity metric (Figure 2). The expression profiles of samples were divided into two groups- one from the non-inoculated swines (M-L-1, M-L-2, M-L-3) and the other group from the inoculated swine (M-L-4, M-L-5, M-L-6).
The principal component map to three-dimensional space, also found that the distance of CG (samples M-L-1, M-L-2, M-L-3) is short, and the gene expression pattern is more consistent. The distance of TG (samples M-L-4, M-L-5, M-L-6) is relatively discrete because of the differences in the lesions degree. The gene expression pattern is similar (Figure 3).
The six samples were set as variables. The principal component analysis (PCA) of the co-expressed differentially genes (CG vs. TG) showed that the contribution rate of the first principal component of which has reached 97.16%. The total contribution rate of the first three principal components reached 99.41% (Table 1).
Table 1.
Principal Component | Eigenvalues | Contribution ratio |
---|---|---|
1 | 42.273 | 97.16% |
2 | 0.978 | 2.25% |
3 | 0.147 | 0.34% |
4 | 0.072 | 0.17% |
5 | 0.025 | 0.06% |
6 | 0.014 | 0.03% |
2.3. Differentially Expressed (DE) Gene Analysis
Of the 9,517 DE genes, 815 were annotated as pig genes in the GenBank database (DB). GO and KEGG pathway analyses of the 815 DE gene lists were conducted using DAVID. There were 272 biological process (BP) categories (Supplementary Table S1), 75 cellular components (Supplementary Table S2), and 171 molecular functions (Supplementary Table S3) were significantly affected by infection with APP (p = 0). There were many BP related to the immune responses, and a number of BP related to metabolism were also identified.
A total of 344 genes were analyzed by pathway enrichment analysis (GSEA). Two hundred and thirty-eight genes (69.19% of the total) were correlated with TG, while the other 106 (30.81%) genes were correlated with CG. One hundred and forty-two of the total 170 pathways remained for further analysis after size filtering (2 ≤ sizes ≤ 20). Altogether, 104/142 pathways (Supplementary Table S4) were enriched and up-regulated in the TG and down-regulated in the CG. Two pathways (namely, VEGF signaling pathway and Long-term potentiation) were significantly enriched at nominal p values of less than 1% and 5%.
Thirty-eight pathways (Supplementary Table S5) were down-regulated in the TG. One pathway (Allograft rejection) was statistically significant at a false discovery rate of <25%. Five pathways (namely, Ribosome, Asthma, Allograft rejection, Type I diabetes mellitus and Cardiac muscle contraction) were significantly enriched at a nominal p value of less than 1% and 5%.
Further analysis revealed that several genes were induced by leading edge analysis for the seven significant pathways (Figure 4). The genes included those encoding v-Ha-ras Harvey rat sarcoma viral oncogene homolog (NRAS), protein phosphatase 1 (PP1), similar to calmodulin (CaM), similar to mitogen-activated protein kinase 14 (MPK14), p101 protein (PI3K), heat shock 27 kDa protein 1 (HSP27), ribosomal protein (RP) S3A and RP SA, among others. The repressed genes comprised those encoding members of the major histocompatibility complex (MHC), including (SLA-1, SLA-3, SLA-DRA, SLA-DRB1, SLA-DMB, SLA-DQA, SLA-DMA), CD40, IL-12B, calcium channel, voltage-dependent, beta 4 subunit (CACNB4), FXYD domain containing ion transport regulator 2 (FXYD2), cytochrome c oxidase polypeptide VIIa-muscle/heart (COX7A1), Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (Fau), RP L27, RP21, RP L36a-like, RP S17, among others.
Genes that were frequently induced in the TG included NRAS, while genes such as SLA-1, SLA-3, SLA-DRA, SLA-DRB, SLA-DMB, SLA-DQA, SLA-DMA, CD40, IL-12B were frequently suppressed.
2.4. Verification of Gene Expression Pattern from Microarray Data Using Real-Time QRT-PCR
Ten genes (namely, RETN, ADAM17, GPNMB, CHRM1, ALDH2, IL6, KLRK1, DUOX2, OAS2 and KCNAB1) were selected to confirm expression patterns using real-time qRT-PCR. The results indicate that the expression patterns of all the genes were consistent with the microarray data (r = 0.875 ± 0.122, Figure 5).
3. Discussion
In the present study, we revealed 9,517 DE genes in HN using Agilent Whole Porcine Genome Oligo Microarrays (one-color platform) that contain 43,603 probes, while 11,929 DE genes in lung tissue [19]. There were 815 genes annotated as swine genes in the GenBank Data Base (DB). GO term analysis identified that a total of 272 BP categories, 75 cellular components and 171 molecular functions were significantly affected and at least 50 BP categories in HN were related to the host immune response (i.e., signaling, signal transmission, signal transduction, response to stimulus, oxidation reduction, response to stress, immune system process, signaling pathway, immune response, cell surface receptor linked signaling pathway), while a total of 89 BP categories, 82 cellular components and 182 molecular functions were significantly affected and 27 BP categories were related to the host immune response in lung [19]. Thus, the body in the course of anti-infective, immune organs adjacent to the infected tissue played more complex biological role, especially immunomodulatory effects.
The environmental information processing and signal transduction pathways (including Long-term potentiation, VEGF signaling pathway, the erbB signaling pathway, the cnt signaling pathway, and the calcium signaling pathway), host immune responses pathways (including Toll-like receptors signaling pathway, NOD-like receptors signaling pathway, RIG-I-like receptors signaling pathway, B cell receptor signaling pathway), cellular processes pathways (including the cell cycle, p53 signaling and apoptosis), and other pathways associated with metabolism (including the citrate cycle, Glycolysis/Gluconeogenesis, fatty acid metabolism, valine, leucine and isoleucine degradation andbeta-Alanine metabolism), etc., were significantly enriched in inflamed HN. While the NOD-like receptors signaling pathway, Fc epsilon RI signaling pathway, acute myeloid leukemia, melanoma, progesterone-mediated oocyte maturation, spliceosome, type II diabetes mellitus and steroid hormone biosynthesis, etc., were significantly enriched in inflamed lung [19]. Five pathways, such as type I diabetes mellitus, autoimmune thyroid disease, allograft rejection, tight junction and cardiac muscle contraction were significantly enriched in non-inflamed lung [19]. The pathways activated in infected lung tissues were also including the acute myeloid leukemia pathway, progesterone-mediated oocyte maturation pathway, steroid hormone biosynthesis pathway, type II diabetes mellitus, spliceosome pathway and melanoma pathway [19].
Long-term potentiation and VEGF signaling pathway were two important pathways implicated in environmental information processing and signal transduction. Long-term potentiation can activate the Erk/MAP kinase and cAMP regulatory pathways [20]. VEGF signaling pathway can lead to a cascade of different signaling pathways, resulting in the up-regulation of genes involved in mediating the proliferation, migration of endothelial cells, promoting their survival and vascular permeability [21–24]. Specific families of pattern recognition receptors responsible for detecting microbial pathogens and generating innate immune responses, including Toll-like receptors (TLRs) [25–27], NOD-like receptors (NLRs) [28,29] and RIG-I-like receptors (RLRs) [30,31], were implicated in the activation of host immune responses pathways. Pathways repressed in inflamed HN, mainly including the MAPK signaling pathway, the TGF-β signaling pathway, antigen processing and presentation, focal adhesion and the adherents junction, amongst other.
Genes shown by leading edge analysis were activated in inflamed HN, including NRAS [32,33], PI3K [34–39], MAPK14 [40], CaM, HSP27, protein phosphatase 3 (formerly 2B), catalytic subunit and alpha isoform (CALN), amongst others. Activations of all these genes were implicated in the proliferation and migration of endothelial cells promoting their survival and vascular permeability. CaM can lead to intracellular activation of NRAS and CALN, whilst MAPK promotes subsequent initiation of DNA synthesis and cell growth. In addition, PI3K leads to increasing endothelial-cell survival. Activation of PI3K, HSP27 and MAPK14 were implicated in cell migration signaling induced response cells as granulocytes (e.g., neutrophils, eosinophils, and basophils) and monocytes migration to the site of inflammation. While the gene encoding IL-6, IL-8, IL-18, TNF, GM-CSF, CCL2, p101 protein, HLA-B associated transcript 1, Fc fragment of IgE, MAPK14, MAP2K1, IGF-1, STAT3 and STAT5B, etc., were activated at the site of inflammation lung [19]. Activations of all these genes can stimulate stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes, and also induce neutrophils and macrophages to phagocytose bacterial and foreign antigens [19].
Those genes encoding members of the major histocompatibility complex (MHC), CD40, IL-12B were repressed in inflamed HN, while immunomodulatory cytokines IL2, IL12B, CD40, members of the MHC (SLA-2, SLA-3, SLA-6, SLA-8, SLA-DRB1, SLA-DMB, SLA-DQA, SLA-DMA and SLA-DQB1) were significantly suppressed at the site of inflamed lung [19]. MHC is a set of molecules (namely, SLA-1, SLA-3, SLA-DRA, SLA-DRB1, SLA-DMB, SLA-DQA, SLA-DMA) displayed on cell surfaces that can present antigenic peptides to T lymphocytes, which are responsible for a specific immune response that can destroy the pathogen producing those antigens [41]. Interactions between the CD4 molecule (found on helper T-cells), class II MHC or the CD8 molecule (found on cytotoxic T-cells) and class I MHC, act to stabilize and consummate the antigen recognition process. This allows helper T-cells to respond to “exogenous” antigens (leading to B-cell activation and the production of antibody), or cytotoxic T-cells to respond to “endogenous” antigens (leading to target cell destruction). CD40 is a co-stimulatory protein found on antigen presenting cells (APCs) and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching and memory B cell development [42–44]. IL12B, the gene encoding the p40 subunit of IL-12 and IL-23 [45], is a potent IFNγ-inducing cytokine secreted by macrophages and dendritic cells [46,47]. IL-12/IL-23 signaling can influence host responses independent of IFN-γ and autocrine IL-12/IL-23 production by APC [45]. IL-12 is also an essential inducer of Th1 cell development, and has an important role sustaining a sufficient number of memory/effector Th1 cells to mediate Long-term protection against an intracellular pathogen [48]. Hence, down-regulation of Cytokines (MHC, CD40 and IL12B) finally leads to a decrease in antigenic peptides presented to T lymphocytes by APCs via the MHC; this influences T cell function, memory B cell and Th1 cell development, and suppresses immune response.
Genes encoding metabolism and ribosomal proteins were affected, induced including PP1 and RP (S3A, SA), repressed including CACNB4, Fau, COX7A1 and RP (S17, S21, L27, L36a-like). Previous studies have shown that 41 out of 54 genes encoding RP were down-regulated in Pseudomonas aeruginosa after treatment with H2O2, a molecule which induces oxidative stress [49].
In the future studies, although additional work including more animals and time points is clearly needed to further delineate the host response to APP infection, the results obtained here demonstrate that: (1) a total of 272 biological process categories, 75 cellular components and 171 molecular functions were significantly affected by APP, and more than 50 biological process were involved in the host immune response against APP; (2) seven differentially expressed gene pathways had statistically significant associations with host responses in TG; (3) many of the cytokines mediating the proliferation and migration of endothelial cells and promoting their survival and vascular permeability were activated in TG; (4) several immunomodulatory cytokines were suppressed in TG. All changes of the genes, GO terms, and pathways which induced or repressed expression, led to decrease in antigenic peptides presented to T lymphocytes by antigen presenting cells (APC) via MHC and alleviated immune response injury induced by infection in HN. The immune response of HN in the APP-infected pigs was weakened; in contrast, cell proliferation and migration signaling was enhanced. Additional work including more animals and time points is clearly needed to further delineate the host response to APP infection and will contribute to a more detailed description of the dynamics of host responses in general.
4. Experimental Section
4.1. Animals, Bacterial Inoculation and Samples
All animal were conducted according to the Regulations for the Administration of Affairs Concerning Experimental Animals (Ministry of Science and Technology, China, revised in June 2004) and approved by the Institutional Animal Care and Use Committee in College of Animal Veterinary Medicine, Sichuan Agricultural University, Sichuan, Chinaunder permit No. DYY11966Twenty 12-week-old male castrated Danish Landrace/Yorkshire/Duroc crossbred swine from a healthy herd free from APP were divided equally into a control group (CG) and the treatment group (TG). APP serotype I (Strain provided by the Animal Biotechnology Center, Laboratory of Animal Disease and Human Health, Sichuan Agricultural University) was cultivated overnight at 37 °C in air on trypticase soy broth (TSB) (Hangwei, Hangzhou City, China). Bacterial counts of the suspensions were performed at the same time as the start of the inoculation. The inoculation was performed by holding the pigs (1–10) from the TG in an upright sitting position and spraying 0.25 mL diluent containing (3.5 – 4) × 107 CFU/mL APP per kilogram weight into the nostrils during inspiration. Swine from the CG (swines 11–20) were inoculated with physiological saline (0.9% w/v NaCl) by the same means. In the TG, HN was collected 48 h post-inoculationfrom three swine (swines 1–3) after abattage and used for total RNA extraction and pathological analysis. Another three swine (swines 11–13) from the CG were sacrificed 48 h post-inoculation and their HN were collected by the same methods. The remaining swine were used for other trials.
4.2. Microarray Hybridizations and Data Analysis
Total RNA was extracted from tissues using Trizol reagent (Invitrogen, Carlsbad, CA, USA). RNA was purified and DNase treated using the RNeasy QIAGEN RNeasy® Mini Kit (QIAGEN, Hilden, Germany). cDNA was synthesized from 2 μg of total-RNA using the direct cDNA Labeling System. Aminoallyl-cRNA was synthesized from cDNA using the Superscript Indirect cDNA Labeling System (Agilent, Palo Alto, CA, USA). The cRNA was purified and DNase treated using RNeasy QIAGEN RNeasy® Mini Kit (QIAGEN, Hilden, Germany). The integrity of total RNA also passed analysis with the Bioanalyzer 2100 (model 2100; Agilent Technologies, Palo Alto, CA, USA) with RIN number > 6.0. Labeling and hybridization of the cRNA was performed with Agilent Whole Porcine Genome Oligo (4 × 44K) Microarrays (one-color platform) at the National Engineering Center for Biochip at Shanghai, according to the manufacturer’s protocols. The slides were scanned and analyzed using the histogram method with default settings in an Agilent G2565AA and Agilent G2565BA Microarray Scanner System using SureScan Technology. The TIFF image generated was loaded into Feature Extraction Software (Agilent Technologies, Sisha Clara, CA, USA) for feature data extraction, and data analysis was performed with MultiExperiment Viewer (MeV) (Boston, MA, USA). The array data has been submitted to gene expression omnibus (GEO) GSE42317 [50].
Comparisons between the CG and the TG were conducted using three biological replicates for each group. CG samples and TG samples were used for microarray analysis. The six Microarray data were normalized using the quantile method [51] with WebarrayDB online microarray data analysis [52]. Data were filtered and assessed by the MIDAW online analysis program [53] using the method of weighted K-nearest neighbor [54]. T-tests for microarray data were performed by a MultiExperiment Viewer (MeV) software package (Version 4.5, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA, USA) [55].
Tests for statistical significance (p < 0.05), overrepresentation of Gene ontology (GO) terms [56,57], and pathway in Kyoto Encyclopedia of Genes and Genomes (KEGG) DB [58,59] among both induced and repressed genes were conducted using the ErmineJ gene set analysis software [60] and the Database for Annotation, Visualization and Integrated Discovery (DAVID) Online platform with a threshold of a minimum three genes annotated at each node. The leading edge analysis for the pathway of differential expression in microarray data with a threshold of a minimum of two genes and maximum of 20 genes annotated at each node were conducted using the gene set enrichment analysis (GSEA) V2.06 package at the GSEA/MSigDB web site (the broad institute) [61–63]. More detailed descriptions of the microarray experiments are available at the NCBI Gene Expression Omnibus [64–66].
4.3. Real-Time QRT-PCR
In order to confirm reliability of the expression profile in the microarray analyses, expression level of the genes (six up-regulated and four down-regulated) were performed by real-time qRT-PCR. Sequences for the primers were obtained from Genbank and NCBI. Primers were designed using the software Primer 5 and synthesized at Invitrogen Co. Led (Shanghai, China) (Table 2). Extracted RNA was converted into cDNA by reverse transcription of 1 μL total RNA using SYBR® PrimeScript™ RT-PCR Kit (TaKaRa, Shiga, Japan) according to the manufacturer’s protocol, and then cDNA was stored at −20 °C until use. Quantitative PCR was performed in a 25 μL reaction volume (2 μL cDNA, 12.5 μL of SYBR® Premix Ex TaqTM (2×) TaKaRa, Shiga, Japan), 0.5 μL of 10 μM upstream and downstream primers respectively, and added ddH2O to 25 μL) on the BIO-RAD IQ5 System (BIO-RAD, Hercules, CA, USA). Real-time PCR conditions were as follows: 30 s at 95.0 °C, 40 cycles of denaturation at 95 °C for 5 s followed by 30 s annealing and elongation at 51.2–60 °C (Table 2). Information of primer pairs is reported in Table 2. Melting curves were obtained at the end of each run to confirm a single PCR product. All samples were run in triplicate. Non-template controls were included in each run to exclude contamination and nonspecific amplification. Expression levels of samples were normalized by using a normalization factor calculated by the program geNorm. This normalization factor was calculated based on RT-qPCR results for three selected reference genes, ACTB, TOP2B and TBP.
Table 2.
Confirmation objects | Gene symbol | Primer sequence (5′→3′) | Amplicon length (bp) | Ta (°C) | GenBank No. |
---|---|---|---|---|---|
Reference gene | ACTB | TCTGGCACCACACCTTCT | 114 | 60 | DQ178122 |
TGATCTGGGTCATCTTCTCAC | |||||
| |||||
TBP | GATGGACGTTCGGTTTAGG | 124 | 60 | DQ178129 | |
AGCAGCACAGTACGAGCAA | |||||
| |||||
TOP2B | AACTGGATGATGCTAATGATGCT | 137 | 60 | AF222921 | |
TGGAAAAACTCCGTATCTGTCTC | |||||
| |||||
Up gene | RETN | AGTGCGCTGGCATAGACTGG | 197 | 60 | NM_213783 |
CATCCTCTTCTCAAGGTTTATTTCC | |||||
| |||||
ADAM17 | TTGAGGAAGGGGAAGCC | 158 | 56 | NM_001099926 | |
ACGGAGCCCACGATGTT | |||||
| |||||
GPNMB | GAGACCCAGCCTTCCTT | 130 | 51.2 | NM_001098584 | |
TTGCTTTCTATCGCTTTGTA | |||||
| |||||
CHRM1 | CGCTGGTCAAGGAGAAGAA | 185 | 56 | NM_214034 | |
GCACATGGGGTTGATGGT | |||||
| |||||
ALDH2 | AAACTGCTCTGCGGTGGA | 181 | 56 | NM_001044611 | |
CGTACTTGGAATTGTTGGCTC | |||||
| |||||
IL6 | GTCGAGGCTGTGCAGATTAG | 101 | 56 | NM_214399 | |
GCATTTGTGGTGGGGTTAG | |||||
| |||||
Down gene | KLRK1 | TGATGTGATAAACCGTGGTG | 107 | 56 | NM_213813 |
TGGATCGGGCAAGGAAA | |||||
| |||||
DUOX2 | CCCTTCTTCAACTCCCTG | 158 | 51.2 | NM_213999 | |
CAAAAGTTCTCATAGTGGTGC | |||||
| |||||
OAS2 | GACACGGCTGAAGGTTT | 291 | 51.2 | NM_001031796 | |
TGGCACGTCCCAAGACT | |||||
| |||||
KCNAB1 | AAGGGAGAAAACAGCAAAAC | 176 | 56 | NM_001105294 | |
AACCTGAATGGCACCGA |
This allowed quantification of the target gene in one sample relative to that in another (the calibrator) using the “2−ΔΔCt method” of calculating fold changes in gene expression [67]. Correlation analysis between qRT-PCR and microarray was conducted.
5. Conclusions
We have generated reliable mRNA transcriptomes of HN from the APP-infected and negative control pigs and identified a set of DE genes in our current case-control study, and a functional enrichment analysis indicated that these DE genes were mainly related to “host immune response” and “host response”. We found that, in the APP-infected HN, many cytokineswere activated and involved in cell migration signaling induced response cells as granulocytes (e.g., neutrophils, eosinophils, and basophils) and monocytes migration to the inflammatory site, while the cytokines involved in regulation of the host immune response were suppressed. The current study provides data that can be used in future studies to decipher the molecular mechanism of the systematic influences from porcine pleuropneumonia.
Supplementary Information
Acknowledgments
We thank the farmer that provided swine. This work was supported financially by the Natural Science Foundation of Science and Technology Department of Sichuan Province.
Conflicts of Interest
The authors declare no conflict of interest. Our experiments involving the use of swine, and the use of pigs and all experimental procedures involving animals were approved by Sichuan Agricultural University Animal Care and Use Committee.
References
- 1.Gottschalk M., Broes A., Mittal K.R., Kobisch M., Kuhnert P., Lebrun A., Frey J. Non-pathogenic Actinobacillus isolates antigenically and biochemically similar to Actinobacillus pleuropneumoniae: A novel species? Vet. Microbiol. 2003;92:87–101. doi: 10.1016/s0378-1135(02)00341-3. [DOI] [PubMed] [Google Scholar]
- 2.Christensen H., Bisgaard M. Revised definition of Actinobacillus sensu strict isolated from animals: A review with special emphasis on diagnosis. Vet. Microbiol. 2004;99:13–30. doi: 10.1016/j.vetmic.2003.12.002. [DOI] [PubMed] [Google Scholar]
- 3.Aarestrup F.M., Jensen N.E. Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark: Evaluation of three different media of MIC-determinations and tablet diffusion tests. Vet. Microbiol. 1999;64:299–305. doi: 10.1016/s0378-1135(97)00119-3. [DOI] [PubMed] [Google Scholar]
- 4.Bossé J.T., Janson H., Sheehan B.J., Beddek A.J., Rycroft A.N., Kroll J.S., Langford P.R. Actinobacillus pleuropneumoniae: Pathobiology and pathogenesis of infection. Microbes Infect. 2002;4:225–235. doi: 10.1016/s1286-4579(01)01534-9. [DOI] [PubMed] [Google Scholar]
- 5.Gutiérrez-Martín C.B., del Blanco N.G., Blanco M., Navas J., Rodríguez-Ferri E.F. Changes in antimicrobial susceptibility of Acti-nobacillus pleuropneumoniae isolated from pigs in Spain during the last decade. Vet. Microbiol. 2006;115:218–222. doi: 10.1016/j.vetmic.2005.12.014. [DOI] [PubMed] [Google Scholar]
- 6.Matter D., Rossano A., Limat S., Vorlet-Fawer L., Brodard I., Perreten V. Antimicrobial resistance profile of Actinobacillus pleurop- neumoniae and Actinobacillus porcitonsillarum. Vet. Microbiol. 2007;122:146–156. doi: 10.1016/j.vetmic.2007.01.009. [DOI] [PubMed] [Google Scholar]
- 7.Rycroft A.N., Garside L.H. Actinobacillus species and their role in animal disease. Vet. J. 2000;159:18–36. doi: 10.1053/tvjl.1999.0403. [DOI] [PubMed] [Google Scholar]
- 8.Taylor D.J. Actinobacillus pleuropneumoniae. In: Straw B.E., D’Allaire S., Mengeling W.L., Taylor D.J., editors. Diseases of Swine. 8th ed. Vol. 26. Iowa State University Press; Ames, IA, USA: 1999. pp. 343–354. [Google Scholar]
- 9.Baarsch M.J., Foss D.L., Murtaugh M.P. Pathophysiologic correlates of acute porcine pleuropneumonia. Am. J. Vet. Res. 2000;61:684–690. doi: 10.2460/ajvr.2000.61.684. [DOI] [PubMed] [Google Scholar]
- 10.Baarsch M.J., Scamurra R.W., Burger K., Foss D.L., Maheswaran S.K., Murtaugh M.P. Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae. Infect. Immun. 1995;63:3587–3594. doi: 10.1128/iai.63.9.3587-3594.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Choi C., Kwon D., Min K., Chae C. In-situ hybridization for the detection of inflammatory cytokines (IL-1, TNF-α and IL-6) in pigs naturally infected with Actinobacillus pleuropneumoniae. J. Comp. Pathol. 1999;121:349–356. doi: 10.1053/jcpa.1999.0332. [DOI] [PubMed] [Google Scholar]
- 12.Huang H., Potter A.A., Campos M., Campos M., Leighton F.A., Willson P.J., Haines D.M., Yates W.D. Pathogenesis of porcine Actinobacillus pleuropneumonia, part II: Roles of proinflammatory cytokines. Can. J. Vet. Res. 1999;63:69–78. [PMC free article] [PubMed] [Google Scholar]
- 13.Wattrang E., Wallgren P., Fossum C. Actinobacillus pleuropneumonia serotype 2-effects on the interferon-alpha production of porcine leukocytes in vivo and in vitro. Comp. Immunol. Microbiol. Infect. Dis. 1998;21:135–154. doi: 10.1016/s0147-9571(97)00025-8. [DOI] [PubMed] [Google Scholar]
- 14.Cho W.S., Jung K., Kim J., Ha Y., Chae C. Expression of mRNA encoding interleukin (IL)-10, IL-12p35 and IL-12p40 in lungs from pigs experimentally infected with Actinobacillus pleuropneumoniae. Vet. Res. Commun. 2005;29:111–122. doi: 10.1023/b:verc.0000047488.05304.3e. [DOI] [PubMed] [Google Scholar]
- 15.Cho W.S., Chae C. Expression of nitric oxide synthase 2 and tumor necrosis factor alpha in swine naturally infected with Actinobacillus pleuropneumoniae. Vet. Pathol. 2002;39:27–32. doi: 10.1354/vp.39-1-27. [DOI] [PubMed] [Google Scholar]
- 16.Moser R.J., Reverter A., Kerr C.A., Beh K.J., Lehnert S.A. A mixedmodel approach for the analysis of cDNA microarray gene expression data from extreme-performing pigs after infection with Actinobacillus pleuropneumoniae. J. Anim. Sci. 2004;82:1261–1271. doi: 10.2527/2004.8251261x. [DOI] [PubMed] [Google Scholar]
- 17.Hedegaard J., Skovgaard K., Mortensen S., Sorensen P., Jensen T., Hornshoj H., Bendixen C., Heegaard P.M.H. Molecular characterisation of the early response in swines to experimental infection with Actinobacillus pleuropneumoniae using cDNA microarrays. Acta Venterinaria Scand. 2007;49:11. doi: 10.1186/1751-0147-49-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mortensen S., Skovgaard K., Hedegaard J., Bendixen C., Heegaard P.M. Transcriptional profiling at different sites in lungs of pigs during acute bacterial respiratory infection. Innate Immun. 2011;17:41–53. doi: 10.1177/1753425909349760. [DOI] [PubMed] [Google Scholar]
- 19.Zuo Z., Cui H., Li M., Peng X., Zhu L., Zhang M., Ma J., Xu Z., Gan M., Deng J., et al. Transcriptional profiling of swine lung tissue after experimental infection with Actinobacillus pleuropneumoniae. Int. J. Mol. Sci. 2013;14:10626–10660. doi: 10.3390/ijms140510626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kelly P.T., Mackinnon R.L., Dietz R.V., Maher B.J., Wang J., et al. Postsynaptic IP3 receptor- mediated Ca2+ release modulates synaptic transmission in hippocampal neurons. Brain Res. Mol. Brain Res. 2005;135:232–248. doi: 10.1016/j.molbrainres.2004.12.018. [DOI] [PubMed] [Google Scholar]
- 21.Munoz-Chapuli R., Quesada A.R., Angel Medina M. Angiogenesis and signal transduction in endothelial cells. Cell. Mol. Life Sci. 2004;61:2224–2243. doi: 10.1007/s00018-004-4070-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zachary I. VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 2003;31:1171–1177. doi: 10.1042/bst0311171. [DOI] [PubMed] [Google Scholar]
- 23.Takahashi H., Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (Lond.) 2005;109:227–241. doi: 10.1042/CS20040370. [DOI] [PubMed] [Google Scholar]
- 24.Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., De Bruijn E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 2004;56:549–580. doi: 10.1124/pr.56.4.3. [DOI] [PubMed] [Google Scholar]
- 25.Uematsu S., Akira S. Toll-like receptors and innate immunity. J. Mol. Med. 2006;84:712–725. doi: 10.1007/s00109-006-0084-y. [DOI] [PubMed] [Google Scholar]
- 26.Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., Godowski P.J., Ulevitch R.J., Knaus U.G. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 2000;1:533–540. doi: 10.1038/82797. [DOI] [PubMed] [Google Scholar]
- 27.Uematsu S., Akira S. Toll-like receptors and Type I interferons. J. Biol. Chem. 2007;282:15319–15323. doi: 10.1074/jbc.R700009200. [DOI] [PubMed] [Google Scholar]
- 28.Shaw M.H., Reimer T., Kim Y.G., Nunez G. NOD-like receptors (NLRs): Bona fide intracellular microbial sensors. Curr. Opin. Immunol. 2008;20:377–382. doi: 10.1016/j.coi.2008.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kanneganti T.D., Lamkanfi M., Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27:549–559. doi: 10.1016/j.immuni.2007.10.002. [DOI] [PubMed] [Google Scholar]
- 30.Saito T., Gale M., Jr. Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity. J. Exp. Med. 2008;205:1523–1527. doi: 10.1084/jem.20081210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Yoneyama M., Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 2009;227:54–65. doi: 10.1111/j.1600-065X.2008.00727.x. [DOI] [PubMed] [Google Scholar]
- 32.Ulkü A.S., Der C.J. Ras signaling, deregulation of gene expression and oncogenesis. Cancer Treat. Res. 2003;115:189–208. [PubMed] [Google Scholar]
- 33.Reuther G.W., Der C.J. The Ras branch of small GTPases: Ras family members don’t fall far from the tree. Curr. Opin. Cell Biol. 2000;12:157–165. doi: 10.1016/s0955-0674(99)00071-x. [DOI] [PubMed] [Google Scholar]
- 34.Brock C., Schaefer M., Reusch H.P., Reusch H.P., Czupalla C., Michalke M., Spicher K., Schultz G., Nürnberg B. Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma. J. Cell Biol. 2003;160:89–99. doi: 10.1083/jcb.200210115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Voigt P., Brock C., Nürnberg B., Schaefer M. Assigning functional domains within the p101 regulatory subunit of phosphoinositide 3-kinase gamma. J. Biol. Chem. 2005;280:5121–5127. doi: 10.1074/jbc.M413104200. [DOI] [PubMed] [Google Scholar]
- 36.Stephens L., Ellson C., Hawkins P. Roles of PI3Ks in leukocytes chemotaxis and phagocytosis. Curr. Opin. Cell Biol. 2002;14:203–213. doi: 10.1016/s0955-0674(02)00311-3. [DOI] [PubMed] [Google Scholar]
- 37.Wymann M.P., Zvelebil M., Laffargue M. Phosphoinositide 3-kinase signalling-which way to target? Trends Pharmacol. Sci. 2003;24:366–376. doi: 10.1016/S0165-6147(03)00163-9. [DOI] [PubMed] [Google Scholar]
- 38.Hirsch E., Katanaev V.L., Garlanda C., Garlanda C., Azzolino O., Pirola L., Silengo L., Sozzani S., Mantovani A., Altruda F., et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science. 2000;287:1049–1053. doi: 10.1126/science.287.5455.1049. [DOI] [PubMed] [Google Scholar]
- 39.Crackower M.A., Oudit G.Y., Kozieradzki I., Sarao R., Sun H., Sasaki T., Hirsch E., Suzuki A., Shioi T., Irie-Sasaki J., et al. Regulation of yocardial contractibility and cell size by distinct PI3K-PTEN signaling pathways. Cell. 2002;110:737–749. doi: 10.1016/s0092-8674(02)00969-8. [DOI] [PubMed] [Google Scholar]
- 40.Gesslein B., Hakansson G., Carpio R., Gustafsson L., Perez M.T., Malmsjö M. Mitogen-activated protein kinases in the porcine retinal arteries and neuroretina following retinal ischemia-reperfusion. Mol. Vis. 2010;16:392–407. [PMC free article] [PubMed] [Google Scholar]
- 41.Abbas A.K., Lichtman A.H. Basic Immunology: Functions and Disorders of the Immune System. 3rd ed. Saunders Elsevier; Philadelphia, PA, USA: 2009. Antigen Capture and Presentation to Lymphocytes; pp. 49–70. [Google Scholar]
- 42.Cheng G., Schoenberger S.P. CD40 signaling and autoimmunity. Curr. Dir. Autoimmun. 2002;5:51–61. doi: 10.1159/000060547. [DOI] [PubMed] [Google Scholar]
- 43.Dallman C., Johnson P.W., Packham G. Differential regulation of cell survival by CD40. Apoptosis. 2003;8:45–53. doi: 10.1023/a:1021696902187. [DOI] [PubMed] [Google Scholar]
- 44.O’Sullivan B., Thomas R. Recent advances on the role of CD40 and dendritic cells in immunity and tolerance. Curr. Opin. Hematol. 2004;10:272–278. doi: 10.1097/00062752-200307000-00004. [DOI] [PubMed] [Google Scholar]
- 45.Van de Vosse E., Ottenhoff H.M. Human host genetic factors in mycobacterial and Salmonella infection: Lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect. 2006;8:1167–1173. doi: 10.1016/j.micinf.2005.10.032. [DOI] [PubMed] [Google Scholar]
- 46.De Jong R., Altare F., Haagen I.A., Elferink D.G., Boer T., van Breda Vriesman P.J.C., Kabel P.J., Draaisma J.M., van Dissel J.T., Kroon F.P., et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science. 1998;280:1435–1438. doi: 10.1126/science.280.5368.1435. [DOI] [PubMed] [Google Scholar]
- 47.Picard C., Fieschi C., Altare F., Al-Jumaah S., Al-Hajjar S., Feinberg J., Dupuis S., Soudais C., Al-Mohsen I.Z., Génin E., et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am. J. Hum. Genet. 2002;70:336–348. doi: 10.1086/338625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715–725. doi: 10.1016/s1074-7613(00)00070-4. [DOI] [PubMed] [Google Scholar]
- 49.Palma M., DeLuca D., Worgall S., Quadri L.E.N. Transcriptome analysis of the response of Pseudomonas aeruginosa to hydrogen peroxide. J. Bacteriol. 2004;186:248–252. doi: 10.1128/JB.186.1.248-252.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Transcriptional profiling of swine lung and hilar node after experimental infection with Actinobacillus pleuropneumoniae. [(accessed on 15 November 2012)]. Available online: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42317.
- 51.Hu J., He X. Enhanced quantile normalization of microarray data to reduce loss of information in gene expression profiles. Biometrics. 2007;63:50–59. doi: 10.1111/j.1541-0420.2006.00670.x. [DOI] [PubMed] [Google Scholar]
- 52.Xia X., McClelland M., Wang Y. WebArray: An online platform for microarray data analysis. BMC Bioinforma. 2005;6:306. doi: 10.1186/1471-2105-6-306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Romualdi C., Vitulo N., Favero M.D., Lanfranchi G. MIDAW: A web tool for statistical analysis of microarray data. Nucleic Acids Res. 2005;33:644–649. doi: 10.1093/nar/gki497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Troyanskaya O., Cantor M., Sherlock G., Brown P., Hastie T., Tibshirani R., Botstein D., Altman R.B. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001;17:520–525. doi: 10.1093/bioinformatics/17.6.520. [DOI] [PubMed] [Google Scholar]
- 55.Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., et al. TM4: A free, open-source system for microarray data management and analysis. Biotechniques. 2003;34:374–378. doi: 10.2144/03342mt01. [DOI] [PubMed] [Google Scholar]
- 56.Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., et al. PCG-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003;34:267–273. doi: 10.1038/ng1180. [DOI] [PubMed] [Google Scholar]
- 57.Bild A., Febbo P.G. Application of a priori established gene sets to discover biologically important differential expression in microarray data. Proc. Natl. Acad. Sci. USA. 2005;102:15278–15279. doi: 10.1073/pnas.0507477102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Aoki-Kinoshita K.F., Kanehisa M. Gene annotation and pathway mapping in KEGG. Methods Mol. Biol. 2007;396:71–91. doi: 10.1007/978-1-59745-515-2_6. [DOI] [PubMed] [Google Scholar]
- 59.Dennis G., Jr., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3. [PubMed] [Google Scholar]
- 60.Lee H.K., Braynen W., Keshav K., Pavlidis P. ErmineJ: Tool for functional analysis of gene expression data sets. BMC Bioinforma. 2005;6:269. doi: 10.1186/1471-2105-6-269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545–15550. doi: 10.1073/pnas.0506580102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Dopazo J. Functional interpretation of microarray experiments. OMICS. 2006;10:398–410. doi: 10.1089/omi.2006.10.398. [DOI] [PubMed] [Google Scholar]
- 63.Gene Set Enrichment Analysis. [(accessed on 15 October 2012)]. Available online: http://www.broadinstitute.org/gsea/index.jsp.
- 64.Gene Expression Omnibus. [(accessed on 7 July 2007)]. Available online: http://www.ncbi.nih.gov/geo/
- 65.Barrett T., Suzek T.O., Troup D.B., Wilhite S.E., Ngau W.C., Ledoux P., Rudnev D., Lash A.E., Fujibuchi W., Edgar R. NCBI GEO: Mining millionsof expression profiles-database and tools. Nucleic Acids Res. 2005;33:562–566. doi: 10.1093/nar/gki022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Edgar R., Domrachev M., Lash A.E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–210. doi: 10.1093/nar/30.1.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.